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Obesity is shown to increase the incidence and severity of infectious diseases and individuals seem to exhibit poor antibody re-
sponse to vaccination due to several inherent immune defects. With the increasing prevalence of impaired glucose tolerance (IGT)
seen in obese individuals, the present study was aimed to investigate the basal immune response and immune response upon
Hepatitis B vaccination (HBV) in an obese rat model WNIN/GR-Ob with impaired glucose tolerance (IGT). Decreased propor-
tions of splenic CD4+ T helper cells and CD3+ T cells were observed in obese animals compared to lean animals. Upon HBV, obese
animals showed reduced cell-mediated immunity and humoral immunity in terms of splenic lymphocyte proliferative response to
Concanavalin A (Con A) and Hepatitis B surface antigen (HBsAg) and HBsAg-speciﬁc IgG response. Innate immunity as assessed
in terms of Tumor Necrosis Factor α (TNF α) and Nitric oxide (NO) production by peritoneal macrophages upon HBV was low
and unchanged, respectively, in obese animals. Thus long-term immunological memory is impaired or altered upon HBV.
1.Introduction
Obesityisoftenassociatedwithincreasedriskofdegenerative
diseases like type 2 diabetes, cardiovascular disease (CVD),
and cancer [1]. However, clinically a positive correlation bet-
ween body weight index and incidence of nosocomial infec-
tions was also observed [2]. Increased infections were re-
ported in genetically obese and diet-induced obese rodent
models. For example, Zucker obese rats showed an increased
susceptibility to Candida albicans infections [3], while
Ob/ObmicedisplayedimpairedimmuneresponsetoListeria
monocytogenes and Candida albicans [4]. In diet-induced
obese (DIO) rodent models, a poor response to Porphy-
romonas gingivalis infection were observed and infection
with inﬂuenza virus seemed to cause high mortality rate in
mice [5, 6].
In obese individuals reduction in lymphocyte numbers
and reduced responsiveness to mitogen were observed [7, 8].
Defects in speciﬁc immunity such as reduced lymphocyte
numbers in spleen, thymus, and peripheral blood have been
reported in Ob/Ob and db/db mice and fa/fa Zucker rats [9].
Diminished responsiveness to mitogen as well as cytotoxic
activity was also seen in these animals [9]. Same was true
in DIO models where reduced lymphocyte response and
altered cytokine secretion were observed [10]. Poor antibody
response was reported in obese individuals and overweight
children’sagainstvaccination[11–13].Furthermore,reduced
lymphocyte function upon HBV was observed in WNIN/Ob
obese rat [14].
In recent years, increased prevalence of obesity in both
the developed and developing countries is accompanied by
a parallel rise in the incidence of impaired glucose tolerance
(IGT)bothinadultsandchildren.Inthiscontext,anattempt
was made to study the immune response in an obese rat
model with IGT. At National Institute of Nutrition, we have
a spontaneously mutated obese rat model, namely, WNIN/
GR-Ob, which exhibits the whole gamut of characteristics of
metabolic syndrome [15–18]. In general, the fasting blood2 ISRN Endocrinology
glucose levels of these obese animals are 90–100mg/dL,
whereas oral lavage with glucose at a dose of 250mg/100g
body weight, the 1h and 2h blood glucose levels, were
beyond 140mg/dL suggesting that the animals exhibited
impaired glucose tolerance [19]. These animals also develop
kidney dysfunction, tumors, and opportunistic infections as
they cross one year of age and their life span is short (1.5
years versus 3 years of normal rats) suggesting an altered
or impaired immune function. In the present study, basal
immune response and immune response to Hepatitis B
vaccine (HBV) was studied in WNIN/GR-Ob obese rat with
IGT.
2.MaterialsandMethods
2.1. Studies on Basic Immune Response
2.1.1. Animals. 90-day old 8 female rats of lean (+/+) and
obese (−/−) phenotypes were obtained from the stock
colony of NCLAS and were fed on standard pellet diet.
Animals were housed individually in the animal facility
with proper temperature (22 ± 2◦C), humidity (50–55%),
and light control (12h light and 12h darkness) and were
provided with ad libitum rat chow and water. The study
design had the approval of the Institutional Animal Ethical
Committee(IAEC).Bloodwascollectedthroughretroorbital
sinus and the animals were sacriﬁced to perform the
following immune parameters.
2.1.2. Body and Spleen Weights. Body weights of the animals
were taken. Animals were euthanized using CO2 inhalation
and spleen was removed aseptically and weighed. The spleen
weight was then normalized to gram body weight.
2.1.3. Splenic Lymphocyte Proliferation Assay. Lymphocyte
proliferation assay was performed as previously described
[20]. Brieﬂy, splenocytes were dissociated by using a stainless
steel screen and adjusted to 1 × 109 cells/L RPMI 1640
medium supplemented with 40,000μg/L gentamycin and
5% FBS (Sigma-Aldrich). 200μL of the cell suspension
was added to each well in a 96-well polystyrene plate and
incubated for 48h at 37◦C, 5% CO2 in the absence and pres-
ence of 2.5μg/mL of Con A (Himedia). After two days the
cultures were pulsed with 0.5μci of [3H] thymidine (speciﬁc
activity 240Bq/mmole; BRIT; Mumbai, India). Twenty-four
hours later, the cells were harvested onto a glass ﬁber ﬁlter.
Radioactivity was then measured using a liquid scintillation
counter (Packard Tri-Carb Liquid Scintillation Counter)
aftertheﬁltershadbeenkeptovernightatroomtemperature.
Each test was performed in triplicates. Splenic lymphocyte
proliferative response was expressed in terms of CPM of Con
A stimulated (T)/CPM of unstimulated cells (C).
2.1.4. Splenic Lymphocyte Subpopulation Measurement. The
splenic lymphocyte subpopulation was measured by im-
munoﬂuorescent antibody staining procedure using ﬂow
cytometry [21] (Partec PAS). Brieﬂy, an aliquot (1-2 mil-
lions) of freshly isolated cells was washed with FACS buﬀer
(PBS with 5% FBS and 0.1% sodium azide) and was stained
with the following antibodies: ﬂuorescein isothiocyanate-
(FITC-) conjugated anti-rat CD4 (clone OX-35); phycoery-
thrin (PE) anti-rat CD3 (clone G4.18); phycoerythrin (PE)
anti-rat CD8a (clone OX-8); puriﬁed anti-rat CD45RA; IgM
and ﬂuorescein-isothiocyanate (FITC-) conjugated rat anti-
mouse IgG1 antibody. Allantibodies wereprocured fromBD
Biosciences. Cells were incubated with antibody for 30min
at 4◦C and then washed three times with FACS buﬀer.
Cells were analyzed with a ﬂow cytometer. The samples
were gated using forward versus 90-degree light scatter to
exclude granulocytes and monocytes from the splenocytes
population. For each test sample, 20,000 cells were analyzed.
2.1.5. Estimation of Serum Immunoglobulins. Total IgG and
IgMlevelsweremeasuredinserumusingcommerciallyavail-
able ELISA kit from Bethyl laboratories Inc. IgG sensitivity
was >7.8ng/mL whereas that of IgM was >31.25ng/mL.
2.1.6. Studies on Immune Response upon Hepatitis B Vaccina-
tion. Fourteen (n = 14) 90-day-old obese and lean female
animals of WNIN/GR-Ob strain were obtained from Na-
tional Centre for Laboratory Animal Sciences (NCLAS).
Six (n = 6) out of these fourteen were grouped as con-
trols or unvaccinated animals and were given Phosphate
Buﬀered Saline (PBS), whereas the remaining eight animals
(n = 8) were grouped as vaccinated and were administered
Hepatitis B vaccine. 4μg of Hepatitis B vaccine (Shanvac
from Shantha Biotech, Hyderabad, India) was administered
intramuscularly and a booster dose was injected one month
after the ﬁrst dose [22]. One week after the booster dose,
blood was collected from the retroorbital sinus vein and the
animals were sacriﬁced to perform the following immune
parameters.
2.1.7. Antigen Speciﬁc Antibody Production. Presence of anti-
bodies to HBsAg (a kind gift from Shantha Biotech) in
the serum was determined by ELISA in ﬂat bottom 96-
well plates (NUNC-Immuno Plate (polySorp)) [23]. Sera of
unvaccinated lean and obese animals were taken as nega-
tive controls. Brieﬂy, the plates were coated with 1μg/mL
(100μL/well) HBsAg in bicarbonate buﬀer (0.1M, pH 9.6)
and incubated overnight at 4◦C. Plates were washed with
a 0.1% solution of Tween-20 in PBS between all steps in
aLabsystemsMicroplateWasher(Finland).Aftercoatingand
washing,theplateswereincubatedwithblockingbuﬀer(PBS
with 0.1% Tween-20 and 2% milk powder) for 1h at 37◦C.
Subsequently, plates were washed and serum at a dilution of
1:5000 was added to the wells. After 1h incubation at room
temperature (RT), the plates were washed and anti-rat IgG
peroxidase conjugate (100μL of 1:5000 dilution) (Sigma-
Aldrich)wasaddedandincubatedfor1h.Plateswerewashed
again and O-Phenylene diamine dihydrochloride (OPD)
0.3mg/mL (Sigma-Aldrich) plus 0.006% H2O2 in 0.15M
citrate buﬀer, pH 5.0, was added. The reaction was stopped
using H2SO4 and the plates were read for absorbance at
492nm in Labsystems ELISA microplate reader.
2.1.8. Isolation and Culture of Peritoneal Macrophages. Peri-
toneal macrophages were obtained by washing the peritonealISRN Endocrinology 3
Table 1: Spleen weight, lymphocyte subsets, lymphocyte proliferative response, and serum IgG and IgM levels in 3-month-old WNIN/GR-
Ob lean and obese rats.
Immune parameters 3 month old WNIN/GR-Ob females
Lean Obese
Spleen weight (mg)/g body weight 2 ± 0.07∗ 1.3 ± 0.05
Total T cells (%) 43.9 ± 1.64∗ 37.0 ± 1.92
T helper cells (%) 38.1 ± 1.58∗ 29.1 ± 1.8
T cytotoxic cells (%) 14.7 ± 0.9 16.8 ± 0.48
Total B cells (%) 29.5 ± 3.22 23.4 ± 1.01
Splenic lymphocyte proliferative response (T/C) 11.6 ± 1.95 7.9 ± 1.85
IgG levels (mg/mL) 2.02 ± 0.184∗ 3.01 ± 0.38
IgM levels (μg/mL) 16.7 ± 1.24∗ 27.7 ± 2.46
Values are in mean ± SE; ∗P<0.05 (signiﬁcant diﬀerence between lean and obese rats).
cavity with 15mL of RPMI 1640 medium [24]. Washed-
out medium was centrifuged at 1200g for 10min at 4◦C.
The pellet containing macrophages was suspended in RPMI
1640 medium enriched with fetal bovine serum (5%) and
gentamycin. Cell viability was determined by the trypan
blue exclusion test and was >95%. Macrophage-rich cultures
were obtained after 2h incubation (37◦C, 5% CO2)o f
1 × 106 cells/mL in 24-well polystyrene culture plates.
Removal of nonadherent cells was done by washing the plate
twice with RPMI 1640. The resulting adherent population
consisted of >95% peritoneal macrophages. The peritoneal
macrophage cultures with and without Lipopolysaccharide
(LPS-1μg/mL) were incubated for 48 h. The culture super-
natants was then taken for the estimation of NO and TNF α
release.
2.1.9. Nitric Oxide and TNF α Production by Peritoneal Mac-
rophages. Nitrite (NO2
−) which is the stable end product
of NO was measured by a colorimetric assay using griess
reagent. Nitrite concentration was calculated from NaNO2
standard curve [25]. The culture supernatant was collected
andstoredat −80◦CuntilfurtheranalysisofTNFαbyELISA
(R&D systems).
2.1.10. Splenic Lymphocyte Proliferation Assay to HBsAg.
Splenic lymphocyte proliferation assay in the presence of
hepatitis B surface antigen at a ﬁnal concentration of
2.5μg/mL was performed as described previously [22].
2.1.11. Determination of Cytokines from Splenocyte Culture
Supernatant. 1 × 106 splenocytes per mL were added to each
well in a 24-well polystyrene plate and incubated for 24h
at 37◦C, 5% CO2 in the absence or presence of 2.5μg/mL
of Concanavalin A. After 24h the culture supernatants were
collected and stored at −80◦C until further analysis of IL 2
and IL 4 by ELISA (R&D systems) [26].
2.1.12. Statistics. Statistical analysis was conducted using
SPSS11.0software.Alldatawerereportedasmean ± SE.The
diﬀerence in the basal immune response between obese and
lean phenotypes was analyzed by Student’s t-test. Immune




































Figure 1: HBsAg-speciﬁc IgG response to Hepatitis B vaccine
in 90-day-old WNIN/GROb lean and obese rats. Values are in
Mean ± SE; ∗P<0.05 (signiﬁcant diﬀerence between unvaccinated
and vaccinated groups of lean and obese rats).
unvaccinated animals of both phenotypes was analyzed by
one way analysis of variance (ANOVA). The signiﬁcant dif-
ferences between groups were identiﬁed by least signiﬁcant
diﬀerence at P<0.05.
3. Results
3.1. Basal Immune Response. The body weight of obese ani-
mals (400 ± 3.9g) was signiﬁcantly higher (209 ± 5.3g)
whereas the spleen weight/g body weight was signiﬁcantly
lower compared to lean females. The obese animals showed
signiﬁcant decrease in CD4+ helper T cells, and CD3+ Tc e l l s
compared to lean animals, whereas the CD8+ cytotoxic T
cells, B cells and splenic lymphocyte proliferative response to
mitogen were comparable between obese and lean animals.
However, the serum IgG and IgM levels were higher in obese
females compared to lean animals (Table 1).
3.2. Immune Response upon Vaccination
3.2.1. HBsAg Speciﬁc IgG Response. Both the obese and lean
animals responded to vaccine by the production of HBsAg
speciﬁc IgG antibody response one week after the booster
dose. Howevertheantibody response wassigniﬁcantlylow in
obese vaccinated as compared to lean vaccinated (Figure 1).
3.2.2. Nitric Oxide (NO) and Tumor Necrosis Factor Alpha
(TNF α) Production by Peritoneal Macrophages. Nitrate pro-
duction by macrophages when stimulated with LPS was sig-
niﬁcantly higher in obese unvaccinated animals compared to4 ISRN Endocrinology
Table 2: Mitogen stimulated IL2 cytokine production by splenocytes and LPS-stimulated TNF-α and NO production by peritoneal macro-
phages to Hepatitis B vaccine in 3-month-old WNIN/GR-Ob lean and obese rats.
Immune parameters WNIN/GR-Ob lean
unvaccinated (n = 6)
WNIN/GR-Ob obese
unvaccinated (n = 6)
WNIN/GR-Ob lean
vaccinated (n = 8)
WNIN/GR-Ob obese
vaccinated (n = 8)
Con A stimulated IL2 production
(ng/mL) 1505 ± 446 1087 ± 149 1423 ± 323 940 ± 290
LPS stimulated TNF-α release
(ng/mL) 1642 ± 748a,b 430 ± 17a,b 1974 ± 449∗a 384 ± 28b
LPS stimulated NO production
(ng/mL) 1.96 ± 0.35∗a 4.4 ± 0.35b 4.7 ± 0.66b 4.25 ± 1.34a,b
Values are in mean ± SE; ∗P<0.05 (signiﬁcant diﬀerence between unvaccinated and vaccinated groups of lean and obese rats). The means bearing similar





















































Figure 2: Splenic lymphocyte proliferative response (T/C ratio) to Con A (a) and HBsAg (b) by incorporation of 3H thymidine in 90-days-
old WNIN/GR-Ob lean and obese vaccinated animals. Values are Mean ± SE; ∗P<0.05 (signiﬁcant diﬀerence between unvaccinated and
vaccinated groups of lean and obese rats).
lean unvaccinated. However, there was increased nitrate pro-
duction in lean vaccinated but not in obese vaccinated. LPS
stimulated TNF α production by peritoneal macrophages
was signiﬁcantly low in obese vaccinated compared to lean
vaccinated (Table 2).
3.2.3. Splenic Lymphocyte Proliferation. In obese and lean
unvaccinated animals the splenic lymphocyte proliferative
response to mitogen was comparable. However, vaccina-
tion induced a signiﬁcant increase in the splenic lym-
phocyte proliferative response to Con A and HBsAg in
lean vaccinated compared to obese vaccinated animals
(Figures 2(a) and 2(b)).
3.2.4. Cytokine Production by Splenocytes. IL4 was not de-
tectable in both stimulated and unstimulated splenocytes
culture supernatant, whereas IL2 was detectable in spleno-
cytesculturesupernatantonly.ConAstimulatedIL2produc-
tion was comparable between obese and lean unvaccinated
and vaccinated animals (Table 2).
4. Discussion
Globally the incidence of IGT has been increasing in obese
children and adults in both the developed and developing
countries [27, 28]. IGT is a prediabetic state and is associated
with increased risk of cardiovascular diseases [29]. Rodent
models have provided useful insights into the pathophysiol-
ogyofobesityandobesity-relatedcomplicationssuchastype
2 diabetes. However, such models are of substantial value
in studying the complications of diabetes and the eﬀect of
prolonged hyperglycemia, but they may be less suitable for
studying the milder changes that occur in the preclinical
stages of type 2 diabetes, that is, prediabetes and the factors
involved in the progression to overt fasting hyperglycemia
and loss of glucose tolerance. Thus, WNIN/GR-Ob obese
rat model with impaired glucose tolerance can be used as
asuitablemodeltostudythemilderchangesthatareinvolved
in the preclinical stages of type 2 diabetes in obese condition.
Obeseratsshowedsigniﬁcantlylowspleenweights,CD4+
helper T cells and CD3+ T cells which is in agreement with
the ﬁndings observed in fa/fa Zucker rats [30, 31]. The
splenic lymphocyte mitogenic response was comparable
between obese and lean animals which is in agreement with
mice-fed high fat diet, but in contrast to fa/fa Zucker rats,
[32]. However, the splenic lymphocyte proliferative response
to mitogen and HBsAg upon HBV was reduced in obese
animals compared to lean animals. Such discrepancies in
response under normal and sensitized conditions were also
observed in db/db, ob/ob mice models where no diﬀerence
was seen in the proliferative activity in vitro but on
sensitization the obese animals exhibited decreased prolif-
erative suggesting a deleterious microenvironment in terms
of altered hormonal and metabolic status [33, 34].
Decreased HBsAg-speciﬁc IgG antibody response was
however, seen similar to obese human subjects, where there
were decreased antibody titers to Hepatitis B vaccine and
tetanus toxoid [11–13] .T h i sc o u l db ea t t r i b u t e dt om e c h a n -
ical factors like insuﬃc i e n td o s er e l a t i v et ob o d ys i z eo r
suboptimal absorption and distribution of the injected
vaccine under obesity [35].ISRN Endocrinology 5
NO generated by macrophages or the antigen-presenting
cells (APCs) during the process of antigen presentation to
T cells contributes to the control of replication or killing of
intracellular microbial pathogens [36]. WNIN/GR-Ob obese
unvaccinated rats showed elevated NO production by peri-
toneal macrophages upon stimulation with LPS compared
with their lean unvaccinated animals. These observations
are in agreement with the ﬁndings observed in db/db mice
wherein the heightened NO production was attributed to the
hyperglycemia observed in those animals [37]. Though the
basalNOlevelswerehigh,vaccinationdidnotleadtofurther
i n c r e a s ei nN Op r o d u c t i o ni no b e s e ,w h i c hw a sh o w e v e r
shown by lean littermates. The blunted NO production by
macrophages observed in WNIN/GR-Ob obese vaccinated
animals may be due to the presence of high basal NO levels
in macrophages of unvaccinated obese rats. Elevated NO in
macrophage was shown to downregulate protein synthesis,
phagocytic activity, respiratory burst, expression of MHC
class II, and suppression of transcriptional activation of
several genes including nitric oxide synthase 2 and may even
trigger their own apoptosis [38]. However, the peritoneal
macrophage NO production by euglycemic WNIN/Ob obese
unvaccinated and vaccinated animals was unaltered [14].
Tumor Necrosis Factor-α (TNF-α)s e c r e t e db ym o n o -
cytes or macrophages upon Lipopolysaccharide (LPS)
stimulation is essential for host defense against bacterial
and other pathogens [39]. Furthermore, it enhances the
antigen presenting capacity and the T-lymphocyte pro-
liferation [40]. There was no signiﬁcant diﬀerence in
the LPS stimulated TNF-α release by peritoneal macro-
p h a g e sb e t w e e no b e s ea n dl e a nu n v a c c i n a t e da n i m a l sw h i c h
is in agreement with the ﬁndings in diet-induced obese rats
[41]. Unlike WNIN/Ob, the LPS stimulated TNF α release
by peritoneal macrophages was decreased in WNIN/GR-
Ob obese vaccinated animals compared to lean vaccinated
animals [14].
Earlier studies had shown that the hormonal and meta-
bolic abnormalities associated with obesity such as hyper-
insulinemia and hyperlipidemia decreases cellular immune
functions such as natural killer cell activity and proliferation
of peripheral blood lymphocytes [42–45]. Apart from the
these factors, it is also shown that in prediabetic state per
se, the lymphomononuclear (LMN) cells change their energy
pathway leading to anaerobic glycolysis and this abnormal
energy production might cause dysfunction in LMN cells
and the immune system in diabetic and prediabetic patients
[46]. Furthermore, an association of Hepatitis C virus with
insulin resistance among adults was observed and abnormal
glucose tolerance was found to be more common in HCV-
seropositiveindividualsthanseronegativeindividualsamong
obese participants suggesting that it could be an additional
risk factor in the impairment of immune function of
WNIN/GR-Ob obese rats [47].
5. Conclusion
WNIN/GR-Ob obese rat with IGT, a suitable model to study
obesity associated prediabetic condition showed impaired
or altered adaptive and innate immunity upon HBV. This
inability of obese animals to respond to HBV has implica-
tions for maintenance of protective immunity and immuno-
logical memory following vaccination.
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